cathepsin D Activators

Cathepsin D Activators comprise a diverse set of chemicals that can indirectly activate cathepsin D by modulating various cellular pathways. Compounds like Retinoic Acid and Dexamethasone can influence gene expression by interacting with nuclear receptors, leading to the activation of cathepsin D. Similarly, EGF and Genistein are involved in growth factor signaling, impacting the epidermal growth factor (EGF) and tyrosine kinase pathways, respectively, thereby facilitating cathepsin D activation. Rapamycin, LY294002, and SB203580 act by inhibiting specific pathways: mTOR, PI3K, and p38 MAPK, respectively, leading to a sequence of downstream effects that include the activation of cathepsin D. Histone deacetylase inhibitors such as Trichostatin A and Sodium Butyrate manipulate chromatin structure, thereby modulating gene expression, including the expression of cathepsin D. Meanwhile, Forskolin is notable for its ability to increase cellular cAMP levels, thereby affecting a plethora of signaling pathways leading to cathepsin D activation. H-89, as a PKA inhibitor, adds another layer of complexity by altering cAMP-related signaling.